251 research outputs found

    Consecuencias del cambio en el uso del suelo sobre la dinámica del agua en dos sistemas semiáridos

    Get PDF
    En los sistemas áridos, la disponibilidad de agua es el principal control de los procesos ecosistémicos. La vegetación ejerce un rol importante sobre los flujos de entrada y salida de agua del sistema, que se verían afectados por cambios en el uso del suelo. En esta tesis se exploraron dos cambios de uso del suelo en distinto sentido, la forestación de pastizales en el noroeste de la estepa patagónica y la delimitación de un área protegida del sureste de la península ibérica. Para el análisis de los flujos hídricos, se combinaron dos aproximaciones, la percepción remota y un modelo de simulación. En Patagonia, las forestaciones evapotranspiraron un 20 por ciento más que la estepa y un 28 por ciento menos que las praderas húmedas (mallines), siendo la transpiración el flujo más afectado. La ausencia de drenaje profundo (aporte indispensable en el balance hídrico de los mallines aledaños)en escenarios forestados, sugeriría que las consecuencias de este tipo de cambio de uso del suelo sobre el rendimiento hídrico de la región se verificarían a escala de paisaje. En el sureste de España la tendencia de la radiación absorbida por la vegetación dentro del parque fue mayor que fuera del mismo. Esto sugeriría que están ocurriendo cambios de distinta magnitud en las situaciones con distinto grado de protección y que la detección de esos cambios requiere de décadas. Cabe destacar entonces, la importancia de evaluar en el corto y largo plazo, no solo la magnitud sino también el sentido de cambio de funcionamiento de los ecosistemas asociados a distintos cambios de uso del territorio, en particular aquellos asociados a la dinámica del agua y el flujo de energía

    Factors affecting egg consumption in young consumers

    Get PDF
    Submitted 2020-06-11 | Accepted 2020-07-09 | Available 2020-12-01https://doi.org/10.15414/afz.2020.23.mi-fpap.1-6The research was carried out on consumers aged 20 to 30 years. The survey was conducted among the young population, on a sample of 200 respondents; male (M, n = 100) and female (F, n = 100). Respondents were asked to answer three sets of questions: a) egg quality indicators; b) which are the benefits of consuming eggs compared to other animal products; and c) which are the disadvantages of consuming eggs. A Likert scale (min = 1, max = 5) was used to evaluate the responses on the factors that influence egg consumption. The respondents (M 4.50 : F 4.11; P 0.05). Interval estimation of the mean values μ in male and female populations was made. The research indicates the attributes that consumers value when choosing and buying products, which can serve as a future guide for egg producers.Keywords: consumption, egg quality, nutritional value, freshnessReferencesBao, P.P., Shu, X.O., Zheng, Y., Cai, N., Ruan, Z.X., Kai, G., Yinghao, S., Yu-Tang, G.,Wei, Z., Wei, L. (2012). Fruit, vegetable and animal intake and breast cancer risk by hormone receptor status. Nutrition Cancer, 64(6), 806-819.Barraj, L., Tran, N., Mink, P. (2009). A Comparison of Egg Consumption with Other Modifiable Coronary Heart Disease Lifestyle Risk Factors: A Relative Risk Apportionment Study. Risk Analysis, 29(3), 401-415.Bejaei, M., Wiseman, K., Cheng, K.M. (2011). Influences of demographic characteristics, attitudes, and preferences of consumers on table egg consumption in British Columbia, Canada. Poultry Science, 90(5), 1088-1095.Bertechini, A.G., Mazzucco, H. (2013). The table egg: A review. Ciência e Agrotecnologia, 37(2), 115-122.Bobetić, B. (2019). The Challenges and Expectations of the EU and Poultry Production in Croatia in the Medium-Term to 2030. Proceedings of 13th Symposium “Poultry Days 2019” with International Participation, May 8 – 11, 2019, (pp. 18-23). In Croatia.Čalić, S., Friganovic, E., Maleš, V., Mustapić, A. (2011). Functional food and consumers. Practical Management, 2(2), 51-57.EBN - Egg Borad Nutritio (2019). Egg composition. Retrived December 22, 2019 from https://www.eggnutritioncenter.org/topics/nutrients-in-eggs/, accessedFernandez, M.L. (2006). Dietary cholesterol provided by eggs and plasma lipoproteins in healthy populations. Current Opinion in Clinical Nutritional and Metabolic Care, 9(1), 8-12.Garza, C., Rasmussen, K.M. (2000). Pregnancy and Lactation. In: Garrow, G.S., James, W.P.T., Ralph, A. (eds.) Human Nutrition and Dietetics (10. Ed.). Churchill Livingstone, London (pp. 437-448).Guter, M.M., Low, E.M. (2008). The British egg marketing board 1957-71-A reassessment. Journal of Agricultural Economics, 22(3), 247-265.Hasler, C.M. (2002). Functional foods: benefits, concerns and challenges - a position paper from the American Council on Science and Health. Journal of Nutrition, 132(12), 3772-3781.Kralik G., Škrtić Z., Kralik Z. (2012). Biometrika u zootehnici. Sveučilište J. J. Strossmayera u Osijeku (pp. 76-81, 91-93).Kralik, I., Kralik Z., Zelić, S. (2014). Consumer preferences of table eggs. Proceedings of 49th Croatian and 9th International Agronomy Symposium. 16-21 February 2014, Faculty of Agriculture University of Josip Juraj Strossmayer in Osijek (pp. 56-160). In Croatia.Kralik, I., Zelić, A., Kralik, G. (2017). Influence of socio-demographic characteristics of examinees on egg quality awareness and consumption. Interdisciplinary management research. 19-21 May 2017, Josip Juraj Strossmayer University of Osijek, Faculty of Economics in Osijek (pp. 1193-1205). In Croatia.Kralik, Z., Rebekic, A. (2018). Consumers preferences on the usefulness In and consumption of enriched products. Krmiva, 60(1), 17-24.Lunven, P., Le Clement de St Marcq, C., Carnovale, E., Fratoni, A. (1973). Amino acid composition of hen`s egg. British Journal of Nutrition, 30(2), 189-194.Missmer, S.A., Smith-Warner, S.A., Spiegelman, D., Yaun, S.S., Adami, H.O., Beeson, W.L. Van den Brandt, P.A., Fraser, G.E., Freudenheim, J.L., Goldbohm, R.A., Graham, S., Kushi, L.H., Miller, A.B., Potter, J.D., Rohan, T.E., Speizer, F.E., Toniolo, P., Willett, W.C., Wolk, A., Zeleniuch-Jacquotte, A., Hunter, D.J. (2002). Meat and diary food consumption in breast cancer: a pooled analysis of cohort studies. International Journal of Epidemiology, 31(1), 78-85.Mutungi, G., Ratliff, J., Puglisi, M., Torres-Gonzalez, M., Vaishnav, U., Leite, J. O., Quann, E., Volek, J. S., Fernandez, M. L. (2008). Dietary cholesterol from eggs increases plasma HDL cholesterol in overweight men consuming a carbohydrate-restricted diet. Journal of Nutrition, 138(2), 272-276.Patil, S.R., Cates, S., Morales, R. (2005). Consumer food safety knowledge, practices and demographic differences: Findings from a meta-analysis. Journal of Food Protection, 68(9), 1884-1894.Official Gazette 115/2006, Ministry of Agriculture, Forestry and Water Management (2006). Rulebook on egg quality. Retrived December 22, 2019 from https://www.poslovni-savjetnik.com/propisi/pravilnik-o-kakvoci-jaja-urednicki-procisceni-tekst-nn-br-1152006-692007-i-762008Ruxton, C.H.S., Derbyshire, E., Gibson, S. (2010). Nutritional properties and health benefits of eggs. Nutrition and Food Science, 40(3), 263-279.Shin, J.Y., Xun, P., Nakamura, Y., He, K. (2013). Egg consumption in relation to cardiovascular disease risk and diabetes: Systematic review and meta-analysis. American Journal of Clinical Nutrition, 98(1), 146-159.Sparks, N.H.C. (2006). The hen`s egg- is its role in human nutrition changing? World`s Poultry Science Journal 62(2), 308-315.Zaheer, K. (2015). An Updated Review on Chicken Eggs: Production, Consumption, Management Aspects and Nutritional Benefits to Human Health. Food and Nutrition Sciences 6(13), 1208-1220.Zelić, A., Kralik, Z., Kralik, I., Mahmutović, H. (2015). Consumer Preferences When Purchasing Table Eggs In The Area Of Tuzla City In Bosnia And Herzegovina. Krmiva, 57(2), 75-79.Zhang, B., X., Pan, M., X., Wang, L., Mo, X.F., Chen, Y.N., Lin, F.Y., Ho, S.C. (2013). Choline and betaine intake is inversely associated with breast cancer risk: a two-stage case-control study in China. Cancer Science, 104(2), 250-258.

    Global media industry in postmodernism: Domination of broadcasting and the tradition of publishing

    Full text link

    Regulation of DJ-1 by glutaredoxin 1 \u3ci\u3ein vivo – implications for Parkinson’s disease\u3c/i\u3e

    Get PDF
    Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, caused by the degeneration of the dopaminergic neurons in the substantia nigra. Mutations in PARK7 (DJ-1) result in early onset autosomal recessive PD, and oxidative modification of DJ-1 has been reported to regulate the protective activity of DJ-1 in vitro. Glutathionylation is a prevalent redox modification of proteins resulting from the disulfide adduction of the glutathione moiety to a reactive cysteine-SH; and glutathionylation of specific proteins has been implicated in regulation of cell viability. Glutaredoxin 1 (Grx1) is the principal deglutathionylating enzyme within cells, and it has been reported to mediate protection of dopaminergic neurons in C. elegans, however many of the functional downstream targets of Grx1 in vivo remain unknown. Previously, DJ-1 protein content was shown to decrease concomitantly with diminution of Grx1 protein content in cell culture of model neurons (SH-SY5Y and Neuro-2A lines). In the current study we aimed to investigate the regulation of DJ-1 by Grx1 in vivo and characterize its glutathionylation in vitro. Here, with Grx−/− mice we provide evidence that Grx1 regulates protein levels of DJ-1 in vivo. Furthermore, with model neuronal cells (SH-SY5Y) we observed decreased DJ-1 protein content in response to treatment with known glutathionylating agents; and with isolated DJ-1 we identified two distinct sites of glutathionylation. Finally, we found that overexpression of DJ-1 in the dopaminergic neurons partly compensates for the loss of the Grx1 homolog in a C. elegans in vivo model of PD. Therefore; our results reveal a novel redox modification of DJ-1 and suggest a novel regulatory mechanism for DJ-1 content in vivo

    BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats

    Get PDF
    Providing NO-system importance, we suggest that one single application of the NOS-blocker L-NAME may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application. A rat retinal ischemia study was conducted throughout 4 weeks, including fundoscopy, behavior presentation, tonometry, and histology assessment. Retrobulbar L-NAME application (5 mg/kg; 0.5 mg/0.1 ml saline/each eye) in rats immediately produced moderate generalized irregularity in the diameter of blood vessels with moderate atrophy of the optic disc and faint presentation of the choroidal blood vessels, and these lesions rapidly progressed to the severe stage. The specific L-NAME–induced vascular failure points to normal intraocular pressure (except to very transitory increase upon drug retrobulbar administration). When BPC 157 (10 μg; 10 ng/kg, as retrobulbar application, 1 μg; 1 ng/0.1 ml saline/each eye) is given at either 20 min after L-NAME or, lately, at 48 h after L-NAME, the regular retrobulbar L-NAME injection findings disappear. Instead, fundoscopy demonstrated only discrete generalized vessel caliber irregularity with mild atrophy of the optic disc, and then, quite rapidly, normal eye background and choroidal blood vessels, which remain in all of the subsequent periods. Also, histology assessment at 1, 2, and 4 weeks shows that BPC 157 counteracted the damaged inner plexiform layer and inner nuclear layer, and revealed normal retinal thickness. The poor behavioral presentation was also rescued. Thus, while further studies will be done, BPC 157 counteracted L-NAME–induced rat retinal ischemia

    Pediatric malignancies presenting as a possible infectious disease

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The clinical, laboratory, and radiological features of malignancy can overlap with those of infection. The purpose of this study was to determine the findings in children who were initially thought to have an infectious disease but ultimately proved to have a malignancy.</p> <p>Methods</p> <p>The database of patients diagnosed with a malignancy in the Northern Alberta Children's Cancer Program (NACCP) January 1, 1993 to December 31, 2003 was merged with the database of inpatients referred to the infectious diseases service at the Stollery Children's Hospital and charts were reviewed on all patients referred to the infectious diseases consult service prior to the diagnosis of malignancy.</p> <p>Results</p> <p>An infectious diseases consultation for diagnosis was requested in 21 of 561 patients prior to the confirmation of malignancy, and 3 of these 21 patients had both infection and malignancy (leukemia (N = 13), lymphoma (N = 3), rhabdomyosarcoma (N = 1), Langerhan's cell histiocytosis (N = 1), fibrous histicocytosis (N = 1), ependymoma (N = 1), and neuroblastoma (N = 1). The most common reason for infectious diseases consultation was suspected muskuloskeletal infection (N = 9). A palpable or radiographically enlarged spleen was noted in 11 patients (52%). All but 2 patients had abnormal hematologic parameters while an elevated lactate dehydrogenase (LDH) occurred in 10 patients (48%). Delay of diagnosis because of investigation or therapy for an infectious disease occurred in only 2 patients.</p> <p>Conclusion</p> <p>It is not common for treatment of pediatric malignancies to be delayed because infection is thought to be the primary diagnosis. However, pediatric infectious diseases physicians should consider malignancy in the differential diagnosis when they see patients with fever and bone pain, unexplained splenomegaly or abnormal complete blood cell counts. Other clues may include hepatomegaly or elevated LDH.</p

    Biocompatibility of implantable materials: an oxidative stress viewpoint

    Get PDF
    Oxidative stress occurs when the production of oxidants surpasses the antioxidant capacity in living cells. Oxidative stress is implicated in a number of pathological conditions such as cardiovascular and neurodegenerative diseases but it also has crucial roles in the regulation of cellular activities. Over the last few decades, many studies have identified significant connections between oxidative stress, inflammation and healing. In particular, increasing evidence indicates that the production of oxidants and the cellular response to oxidative stress are intricately connected to the fate of implanted biomaterials. This review article provides an overview of the major mechanisms underlying the link between oxidative stress and the biocompatibility of biomaterials. ROS, RNS and lipid peroxidation products act as chemo-attractants, signalling molecules and agents of degradation during the inflammation and healing phases. As chemo-attractants and signalling molecules, they contribute to the recruitment and activation of inflammatory and healing cells, which in turn produce more oxidants. As agents of degradation, they contribute to the maturation of the extracellular matrix at the healing site and to the degradation of the implanted material. Oxidative stress is itself influenced by the material properties, such as by their composition, their surface properties and their degradation products. Because both cells and materials produce and react with oxidants, oxidative stress may be the most direct route mediating the communication between cells and materials. Improved understanding of the oxidative stress mechanisms following biomaterial implantation may therefore help the development of new biomaterials with enhanced biocompatibility

    Dihydropyridine Derivatives as Cell Growth Modulators In Vitro

    Get PDF
    The effects of eleven 1,4-dihydropyridine derivatives (DHPs) used alone or together with prooxidant anticancer drug doxorubicin were examined on two cancer (HOS, HeLa) and two nonmalignant cell lines (HMEC, L929). Their effects on the cell growth (3H-thymidine incorporation) were compared with their antiradical activities (DPPH assay), using well-known DHP antioxidant diludine as a reference. Thus, tested DHPs belong to three groups: (1) antioxidant diludine; (2) derivatives with pyridinium moieties at position 4 of the 1,4-DHP ring; (3) DHPs containing cationic methylene onium (pyridinium, trialkylammonium) moieties at positions 2 and 6 of the 1,4-DHP ring. Diludine and DHPs of group 3 exerted antiradical activities, unlike compounds of group 2. However, novel DHPs had cell type and concentration dependent effects on 3H-thymidine incorporation, while diludine did not. Hence, IB-32 (group 2) suppressed the growth of HOS and HeLa, enhancing growth of L929 cells, while K-2-11 (group 3) enhanced growth of every cell line tested, even in the presence of doxorubicin. Therefore, growth regulating and antiradical activity principles of novel DHPs should be further studied to find if DHPs of group 2 could selectively suppress cancer growth and if those of group 3 promote wound healing
    corecore